A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2004
11/03/2004	CN1541704A Osteoprosis treating medicament and osteoclast creating inhibitor
11/03/2004	CN1541696A Oyster capsule for gastric disease and its preparation
11/03/2004	CN1541658A Cod-liver oil, royal jelly freeze-dry powder capsule and its process
11/03/2004	CN1541657A Medicinal periplaneta americana extracturm extracting process
11/03/2004	CN1541656A Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
11/03/2004	CN1541655A Nano-scale pearl powder preparation method
11/03/2004	CN1541654A Donkey-hide gelatin freeze-dry powder capsule and its process
11/03/2004	CN1173990C Depsipeptide compound
11/03/2004	CN1173732C Traditional Chinese medicine pills for skin and venereal disease and urinary system infection
11/03/2004	CN1173731C Use of Traditonal Chinese medicine composition for curing chronic hepatitis B fibrosis in preparation of medicine for pulmonary fibrosis of SARS
11/03/2004	CN1173728C Medicine for delaying senility and its preparing process
11/03/2004	CN1173727C Chinese medicine liquor for clearing and activating main and collateral channels, and its preparation method
11/03/2004	CN1173726C Medicine for curing malignant turnor and its preparation method
11/03/2004	CN1173725C Traditional Chinese prepared medicine for treating hyperthyreosis and simple thyrocele and its preparing process
11/03/2004	CN1173722C Chinese medicine for treating femur head necrosis and its preparing process
11/03/2004	CN1173721C External-use ointment
11/03/2004	CN1173719C Preparation of hemorrhoids treating capsule
11/03/2004	CN1173718C Medicine for curing rheumatism arising from immune diease lupus erythematosus
11/03/2004	CN1173715C Medicine pill for preventing and treating pathological senility
11/03/2004	CN1173714C Chinese-medicinal capsule for preventing and treating cerebral apoplexy
11/03/2004	CN1173712C Compound preparation containing medicinal active bacteria and its preparation
11/03/2004	CN1173711C Donkey-hide gelatin capsule
11/03/2004	CN1173710C Treatment of congestive heart failure by pretreated autologous blood
11/02/2004	US6812213 Steroidal sapogenins and their derivatives for treating alzheimer's disease
11/02/2004	US6812037 Antimitotic compounds
11/02/2004	US6812027 Therapy for brain disorders
11/02/2004	US6811786 Mixed with bifidogenic oligosaccharide; increasing high density lipoproteins
11/02/2004	US6811778 Method for improving oxygen transport by stored red blood cells
11/02/2004	US6811777 Compositions and minimally invasive methods for treating incomplete connective tissue repair
11/02/2004	US6811776 Process for ex vivo formation of mammalian bone and uses thereof
11/02/2004	US6811775 Reovirus for the treatment of cellular proliferative disorders
11/02/2004	US6811774 Defective recombinant adenoviruses expressing cytokines for antitumor treatment
11/02/2004	CA2283676C Stimulation, culture and preservation of pancreatic and other cells
11/02/2004	CA2068548C Automated process for preparing treated microparticles, especially blood cell components
10/2004
10/28/2004	WO2004092360A2 The severe acute respiratory syndrome coronavirus
10/28/2004	WO2004092348A2 Method for production of oncolytic adenoviruses
10/28/2004	WO2004091637A2 System capable of treating and defining various diseases using stem cells
10/28/2004	WO2004091505A2 Bacteriophage for lysis of methylobacterium and compositions and uses thereof
10/28/2004	WO2004091495A2 Compositions and methods related to production of erythropoietin
10/28/2004	WO2004091435A2 Osteoinductive bone material
10/28/2004	WO2004083375A3 Methods of promoting the differentiation of stem cells
10/28/2004	WO2004078915A3 Cell culture
10/28/2004	WO2004047766A3 Treatment for sma disease
10/28/2004	WO2004043481A3 Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto
10/28/2004	WO2003105908A3 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
10/28/2004	WO2003100005A3 Universal chimera bank
10/28/2004	WO2003095613A3 Nucleic acids, polypeptides, and methods for modulating apoptosis
10/28/2004	WO2003077840A3 Method of modulating inflammatory response
10/28/2004	WO2003022882A3 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
10/28/2004	US20040214771 Cleaved serum response factor in cardiac diagnosis and therapy
10/28/2004	US20040214761 induction of apoptosis in tumor cells by administering monoclonal antibodies
10/28/2004	US20040214754 Ophthalmic preparation containing glycomacropeptide
10/28/2004	US20040214332 Stable, multipotent transgenic nervous system progenitor tissue for treatment and prevention of neurodegenerative disorders
10/28/2004	US20040214304 Microbiocidal gastrointestinal microorganism for use in food processing and the prevention of infection; bacteriocin
10/28/2004	US20040214261 culturing genetically modified microorganism containing polyglutamyl hydrolase (from rodents, mammals, or humans) activity to enhance generation of monoglutamyl folate; food processing; dairy products
10/28/2004	US20040214241 Enhancing culture for osteoblast using immunomagnetic separation; treating osteoporosis
10/28/2004	US20040214234 Method
10/28/2004	US20040214172 Sheeplice, bovicola ovis, allergen treatment
10/28/2004	US20040214158 Treatment of human papillomavirus (hpv)-infected cells
10/28/2004	US20040213856 Compositions and methods for treatment of multiple myeloma
10/28/2004	US20040213799 Boosting priming composition with nonreplicating and/or replication impaired strains of poxvirus vectors; forming human immunodeficiency virus inhibitors
10/28/2004	US20040213770 Methods and systems for treating ischemic cardiac and other tissues
10/28/2004	US20040213768 a cell population capable of producing one or more factors, or a cell culture capable of producing one or more factors or conditioned media from a cell culture containing one or more factors
10/28/2004	US20040213767 Methods for using adipose-derived cells for healing of aortic aneurysmal tissue
10/28/2004	US20040213764 Adenovirus replication-competent vectors expressing trail
10/28/2004	US20040213753 administrating to a skin or hair of a candidate a sponge protein hydrolysate which is a product by acidic hydrolysis of sponge skeleton fibers (spongin fibers) obtained from refined sponges as the raw material in an amount effective to stimulate cell growth of the skin or hair
10/28/2004	DE202004012901U1 Lactobacillus salivarius strain capable of colonizing the gastrointestinal tract of pigeons and ornamental birds, useful for biological control of pathogenic microorganisms
10/28/2004	DE10043937B4 Herstellung einer dreiwertigen Chromkomplexverbindung und eines selbige enthaltenden Milchprodukts Producing a trivalent chromium complex compound and a selbige containing milk product
10/28/2004	CA2548643A1 System capable of treating and defining various diseases using stem cells
10/28/2004	CA2523693A1 Bacteriophage for lysis of methylobacterium and compositions and uses thereof
10/28/2004	CA2521979A1 Compositions and methods related to production of erythropoietin
10/28/2004	CA2521623A1 Osteoinductive bone material
10/28/2004	CA2463487A1 Tumours treating combinations, compositions and methods
10/28/2004	CA2463464A1 Methods of treatment and compositions therefor
10/27/2004	EP1471146A2 A packaging cell line expressing for use in facilitating the development of high capacity adenoviral vectors
10/27/2004	EP1470821A2 Cell therapy method for the treatment of tumours
10/27/2004	EP1470231A2 Methods of obtaining isoform specific expression in mammalian cells
10/27/2004	EP1470218A2 Corona-virus-like particles comprising functionally deleted genomes
10/27/2004	EP1470161A1 Bispecific antibody dna constructs for intramuscular administration
10/27/2004	EP1469927A1 Method and apparatus for producing plant extracts
10/27/2004	EP1469891A1 Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
10/27/2004	EP1469888A2 Stem cell screening and transplantation therapy for hiv infection
10/27/2004	EP1469874A1 The use of melagatran for the manufacture of a medicament for the treatment of type 1 diabetes mellitus
10/27/2004	EP1469733A2 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
10/27/2004	EP1469730A2 Methods and compositions for treating parkinson's disease
10/27/2004	EP1416944A4 Composition for treatment of articular cartilage damage
10/27/2004	EP1276851B1 Tolerance-inducing thymus-bone marrow composite tissue construct and organ
10/27/2004	EP1250050B1 Method and device for sanitation using bacteriophages
10/27/2004	EP1237578A4 Micro-cluster liquids and methods of making and using them
10/27/2004	EP1137424B9 Preparation which contains oligosaccharides and probiotics
10/27/2004	CN1541265A Identification of DNA variant associated with adult type hypolactasia
10/27/2004	CN1541172A ALbumin in flexible polymeric container
10/27/2004	CN1541101A Methods of polyvalent bacteriophage prepn. for treatment of bacterial infections
10/27/2004	CN1539970A Heterophil neutral leucocyte factor alpha
10/27/2004	CN1539945A Health preserving wine
10/27/2004	CN1539484A Vulnerary for treating fracture
10/27/2004	CN1539462A Health product of compound propolis and preparing method
10/27/2004	CN1539431A Powder of Chinese forest frog oil preparation method
10/27/2004	CN1539430A Medication combinaton for treating skin disease and preparation technique
10/27/2004	CN1173033C Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors

1 ... 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 ... 1259